Clinical Trial for Veterans with PTSD Has Already Obtained Approval from U.S. Food and Drug Administration, U. Arizona Institutional Review Board, and U.S. Department of Health and Human Services
Wednesday, April 2: Veterans, Military Family Members and Supporters to Rally at Wesley Bolin Memorial Plaza
After 22 years of hard-fought efforts, the non-profit pharmaceutical company MAPS has finally obtained approval from the U.S. Department of Health and Human Services (HHS) for a FDA clinical trial to examine the medical safety and efficacy of marijuana. The trial would study military veterans suffering from treatment-resistant post-traumatic stress disorder (PTSD). Yet the study’s ability to receive Arizona state funding is in jeopardy due to State Senator Kimberly Yee.